Profilo
Richard E.
Armer, formerly a Research Director at Lectus Therapeutics Ltd., Principal at Pfizer Inc., Ardana Plc, and Oxagen Ltd., and Chief Scientific Officer at Redx Pharma Plc (2014-2024).
Precedenti posizioni note di Richard E. Armer
| Società | Posizione | Fine |
|---|---|---|
| REDX PHARMA LIMITED | Direttore Tecnico/Scientifico/R&S | 01/04/2024 |
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Develops novel molecule drugs to treat inflammatory and respiratory diseases | Corporate Officer/Principal | - |
Ardana Plc
Ardana Plc Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals products | Corporate Officer/Principal | - |
| PFIZER INC. | Corporate Officer/Principal | - |
Lectus Therapeutics Ltd.
Lectus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Developed ion channel modulators and therapeutics | Direttore Tecnico/Scientifico/R&S | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Ardana Plc
Ardana Plc Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals products | Health Technology |
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Develops novel molecule drugs to treat inflammatory and respiratory diseases | Health Technology |
Lectus Therapeutics Ltd.
Lectus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Developed ion channel modulators and therapeutics | Health Technology |
Redx Pharma Plc
Redx Pharma Plc BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on developing novel, small molecule and targeted medicines for fibrotic disease | Health Technology |
















